Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Welltower Reports First Quarter 2018 Results

Welltower
Posted on: 26 Apr 18

TOLEDO, Ohio, April 25, 2018 /PRNewswire/ -- Welltower Inc. (NYSE: WELL) today announced results for the quarter ended March 31, 2018. For the quarter, we generated net income attributable to common stockholders of $1.17 per share and normalized FFO attributable to common stockholders of $0.99 per share.

Quarterly Highlights

Delivered $137 million of pro rata development projects with an expected stabilized yield of 9.3%

Funded $476 million in pro rata new property acquisitions at a blended yield of 6.7%

Generated $987 million of pro rata proceeds from property sales and loan payoffs at a blended yield of 6.7%

Reduced Net Debt to Undepreciated Book Capitalization to 35.3% from 35.8% at March 31, 2017

"In a challenging environment for seniors housing, we have delivered a quarter in line with expectations and with positive same store growth," commented CEO Tom DeRosa. "We completed $613 million of acquisitions and developments, including three of the previously announced rental CCRC communities in top markets managed by Sunrise Senior Living, and will continue to grow with our best-in-class partners through our relationship investing model."

Capital Activity On March 31, 2018, we had $203 million of cash and cash equivalents and $2.1 billion of available borrowing capacity under our primary unsecured credit facility. During the quarter, we extinguished $183 million of secured debt at a blended average interest rate of 5.8% and repaid our 2.25% $450 million senior unsecured notes at par on maturity of March 15, 2018. In April 2018, we completed the issuance of 4.25% $550 million senior unsecured notes maturing in April 2028. Simultaneous with the notes offering, we executed a $550 million USD-to-GBP cross currency swap, resulting in an effective interest rate of 3.11%.

Dividend The Board of Directors declared a cash dividend for the quarter ended March 31, 2018 of $0.87 per share. On May 23, 2018, we will pay our 188th consecutive quarterly cash dividend to stockholders of record on May 8, 2018. The Board of Directors also declared a quarterly cash dividend on the Series I Cumulative Convertible Perpetual Preferred Stock of $0.8125 per share, payable July 16, 2018, to stockholders of record on June 29, 2018.

Post Quarter Investment Activity As announced earlier today, a newly formed strategic partnership between Welltower and ProMedica has jointly entered into a definitive agreement to acquire the real estate of Quality Care Properties, Inc. ("QCP") simultaneous to ProMedica entering into a definitive agreement to acquire the operations of HCR ManorCare. Under the terms of the agreement, which have been unanimously approved by Welltower's, ProMedica's and QCP's Boards of Directors, QCP's shareholders will receive $20.75 in cash for each share of QCP common stock. Welltower will also assume all outstanding QCP debt. The details of this agreement and an accompanying presentation deck can be found at www.welltower.com/investors.

Quarterly Investment and Disposition Activity We completed $578 million of pro rata gross investments for the quarter including $476 million in acquisitions/JVs, $59 million in development funding and $43 million in loans.  67% of these investments were completed with existing relationships. Acquisitions/JVs were comprised of five separate transactions at a blended yield of 6.7%. The development fundings are expected to yield 8.0% upon stabilization and the loans were made at a blended rate of 5.9%. We also placed six development projects into service totaling $137 million at a blended stabilized yield of 9.3%. Also during the quarter, we completed total dispositions of $987 million consisting of loan payoffs of $92 million at an average yield of 7.2% and property sales of $895 million at a blended yield on proceeds of 6.7%.

Notable Investments with Existing Operating Partners

Sunrise As previously announced, we expanded our relationship with Sunrise by entering into a definitive agreement to acquire a portfolio of four rental continuing care retirement communities located in the Washington D.C. (2), Miami, and Charlottesville MSAs.  Welltower will acquire 100% of the landlord's ownership interest for $368 million and will transition the communities to a RIDEA structure with Sunrise continuing to manage the communities under an incentive-based management contract.  The year one cap rate is 7.0%.  We closed on one community in December 2017 for $55 million and two communities in March 2018 for $217 million.  The remaining community is expected to close in the second quarter of 2018 at a price of $96 million.  Since our initial $243 million acquisition in 2012, we have completed $5.5 billion of follow-on pro rata investments with Sunrise.

Florida Medical Clinic Physician Group We acquired a 100% interest in two affiliated outpatient medical buildings in the Tampa MSA.  The purchase price was $43 million, which represents a year one cap rate of 5.8%. The properties combined are 104,828 rentable square feet, have an average age of two years and are 100% master leased to Florida Medical Clinic. Florida Medical Clinic is a physician's group with over 200 doctors and 25 specialties in 49 patient care sites throughout the Tampa MSA. Florida Medical Clinic leases over 400,000 square feet in Welltower properties.

Silverado Senior Living We expanded our relationship with Silverado by acquiring through our existing 95/5 joint venture, a 90-bed private pay memory care property located in the Phoenix MSA. The property was purpose built by Silverado in 2014 and the purchase price of $24 million (based on a 100% ownership interest) represents a year one cap rate of approximately 6.4%. Since closing our initial $4.4 million loan in 1998, we have completed $542 million of follow-on pro rata investments with Silverado.

Notable Investments with New Operating Partners

Cogir Management Corporation As previously announced, we initiated a relationship with Cogir Management Corporation in Canada through the acquisition of six independent living communities with 1,466 units located in Montreal (4) and Quebec City (2), two of Canada's top 10 MSAs. The communities were acquired through the formation of a new 95/5 RIDEA joint venture with Cogir and the purchase price, based on a 100% interest, was $248 million CAD. The year one cap rate is 6.5%. Cogir is the third largest seniors housing operator in Canada with over 8,100 units, and currently manages seven properties in Quebec on behalf of the Welltower/Revera joint venture.

Notable Development Conversions

Brandywine Senior Living We expanded our relationship with Brandywine by completing the development of a 116-unit private pay senior housing property located in the Washington D.C. MSA.  The total investment amount based upon 100% ownership interest was $60 million and the property was added to an existing master lease in a 95/5 joint venture at an initial lease yield of 7.0%.  There are outsized annual escalators for the first five years of the lease followed by 25 basis point annual escalators thereafter.  Since closing our initial $599 million acquisition/leaseback in 2010, we have completed $421 million of follow-on pro rata investments with Brandywine.

Signature Senior Lifestyle We expanded our relationship with Signature by completing the development of a 95-unit assisted living and memory care property in the Greater London MSA. Revera is a 25% joint venture partner on the investment. Total development costs at 100% ownership of £27 million represent a stabilized return on cost of 13%. Since closing our initial $37 million acquisition in 2012, we have completed $679 million of follow-on pro rata investments and financings with Signature.

Notable Dispositions

Aurora Health Care We completed the disposition to Aurora of 18 outpatient medical buildings master leased by them totaling 1.4 million square feet for pro rata proceeds of $429 million, which represents a 5.95% cap rate on in-place rent.  We realized a gain on the sale of $214 million gain and unlevered IRR of 13.4%.

Cascade We completed the disposition of a 22-property portfolio located throughout the Western United States for $378 million.  $24 million of Welltower loans associated with the portfolio were also paid off at closing.  The portfolio was sold to a private investor and Cascade will continue to operate the properties.  We realized a gain on the sale of $103 million and an unlevered IRR of 13.0%. 

Life Care Centers of America We completed the disposition of three long-term/post-acute care facilities and one seniors housing triple-net facility to Life Care Centers of America for $75 million, which represents a 6.8% cap rate on in-place NOI before rent. Life Care Centers of America will continue to operate the properties. We realized a gain on the sale of $20 million and an unlevered IRR of 8.9%.

Genesis Healthcare We received $68 million in loan repayments from Genesis at an average yield of 7%. We also advanced $24 million of new funding, pursuant to a term loan under which Welltower is a co-lender with Omega Healthcare Investors, at a cash yield of 5% and an economic yield of 13% inclusive of PIK.

Outlook for 2018 Net income attributable to common stockholders has been revised upward to a range of $2.55 to $2.65 per diluted share from the previous range of $2.38 to $2.48 per diluted share, primarily due to changes in projected net gains/losses/impairments and depreciation and amortization partially offset by the normalizing items in Exhibit 2. Given the variability of timing related to the completion of the ProMedica joint venture and purchase of QCP, we are not incorporating increased acquisition activity guidance into our earnings guidance at this time. We are affirming our 2018 normalized FFO attributable to common stockholders guidance of $3.95 to $4.05 per diluted share.  In preparing our guidance, we have updated or confirmed the following assumptions:

Same Store NOI: We continue to expect average blended SSNOI growth of approximately 1.0%-2.0% in 2018.

Acquisitions: We are updating 2018 acquisition guidance to include $2.2 billion of investments anticipated to close at year end in addition to investment activity that has already been announced.

Development: We anticipate funding development of approximately $229 million in 2018 relating to projects underway on March 31, 2018. We expect development conversions during the remainder of 2018 of approximately $247 million, which are currently expected to generate stabilized yields of approximately 7.7%.

Dispositions: We are increasing anticipated disposition proceeds from $1.3 billion to $1.9 billion at a blended yield of 7.0% in 2018. This includes approximately $1 billion of proceeds from dispositions completed to-date and $0.9 billion of incremental proceeds from other potential loan payoffs and property sales. The incremental dispositions are not included in our earnings guidance due to uncertainty as to the timing of closing.

Our guidance does not include any additional investments, dispositions or capital transactions beyond what we have announced, nor any other expenses, impairments, unanticipated additions to the loan loss reserve or other additional normalizing items.  Please see the exhibits for a reconciliation of the outlook for net income available to common stockholders to normalized FFO attributable to common stockholders.  We will provide additional detail regarding our 2018 outlook and assumptions on the first quarter 2018 conference call.

Conference Call Information We have scheduled a conference call on Thursday, April 26, 2018 at 8:00 a.m. Eastern Time to discuss our first quarter 2018 results, industry trends, portfolio performance and outlook for 2018. Telephone access will be available by dialing 888-346-2469 or 706-758-4923 (international).  For those unable to listen to the call live, a taped rebroadcast will be available beginning two hours after completion of the call through May 10, 2018. To access the rebroadcast, dial 855-859-2056 or 404-537-3406 (international).  The conference ID number is 2198225. To participate in the webcast, log on to www.welltower.com 15 minutes before the call to download the necessary software.  Replays will be available for 90 days.

Supplemental Reporting Measures We believe that net income and net income attributable to common stockholders (NICS), as defined by U.S. generally accepted accounting principles (U.S. GAAP), are the most appropriate earnings measurements. However, we consider funds from operations (FFO) and same store net operating income (SSNOI) to be useful supplemental measures of our operating performance. These supplemental measures are disclosed on our pro rata ownership basis. Pro rata amounts are derived by reducing consolidated amounts for minority partners' noncontrolling ownership interests and adding our minority ownership share of unconsolidated amounts. We do not control unconsolidated investments. While we consider pro rata disclosures useful, they may not accurately depict the legal and economic implications of our joint venture arrangements and should be used with caution.

Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (NAREIT) created FFO as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO attributable to common stockholders, as defined by NAREIT, means net income attributable to common stockholders, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairments of depreciable assets, plus real estate depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests.  Normalized FFO attributable to common stockholders represents FFO attributable to common stockholders adjusted for certain items detailed in Exhibit 2.  We believe that normalized FFO attributable to common stockholders is a useful supplemental measure of operating performance because investors and equity analysts may use this measure to compare the operating performance of the company between periods or as compared to other REITs or other companies on a consistent basis without having to account for differences caused by unanticipated and/or incalculable items.

We define NOI as total revenues, including tenant reimbursements, less property operating expenses.  Property operating expenses represent costs associated with managing, maintaining and servicing tenants for our seniors housing operating and outpatient medical properties.  These expenses include, but are not limited to, property-related payroll and benefits, property management fees paid to operators, marketing, housekeeping, food service, maintenance, utilities, property taxes and insurance.  General and administrative expenses represent costs unrelated to property operations or transaction costs.  These expenses include, but are not limited to, payroll and benefits, professional services, office expenses and depreciation of corporate fixed assets. SSNOI is used to evaluate the operating performance of our properties under a consistent population which eliminates changes in the composition of our portfolio.  As used herein, same store is generally defined as those revenue-generating properties in the portfolio for the relevant year-over-year reporting periods.  Land parcels, loans, sub-leases and major capital restructurings as well as any properties acquired, developed/redeveloped, transitioned, sold or classified as held for sale during that period are excluded from the same store amounts.  Normalizers include adjustments that in management's opinion are appropriate in considering SSNOI, a supplemental, non-GAAP performance measure.  None of these adjustments, which may increase or decrease SSNOI, are reflected in our financial statements prepared in accordance with U.S. GAAP.  Significant normalizers (defined as any that individually exceed 0.50% of SSNOI growth per property type) are separately disclosed and explained in the relevant supplemental information package. We believe SSNOI provides investors relevant and useful information because it measures the operating performance of our properties at the property level on an unleveraged basis. No reconciliation of the forecasted range for SSNOI on a combined or segment basis is included in this release because we are unable to quantify certain amounts that would be required to be included in the comparable GAAP financial measure without unreasonable efforts, and we believe such reconciliation would imply a degree of precision that could be confusing or misleading to investors.

We measure our credit strength partly in terms of leverage ratios. The leverage ratios indicate how much of our balance sheet capitalization is related to long-term debt, net of cash and Internal Revenue Code ("IRC") Section 1031 deposits. We expect to maintain capitalization ratios sufficient to maintain a capital structure consistent with our current profile. Our leverage ratios include net debt to undepreciated book capitalization. Undepreciated book capitalization represents book capitalization adjusted for accumulated depreciation and amortization. Book capitalization represents the sum of net debt (defined as total long-term debt less cash and cash equivalents and any IRC Section 1031 deposits), total equity and redeemable noncontrolling interests.

Our supplemental reporting measures and similarly entitled financial measures are widely used by investors, equity and debt analysts and ratings agencies in the valuation, comparison, rating and investment recommendations of companies.  Our management uses these financial measures to facilitate internal and external comparisons to historical operating results and in making operating decisions.  Additionally, they are utilized by the Board of Directors to evaluate management.  The supplemental reporting measures do not represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity.  Finally, the supplemental reporting measures, as defined by us, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies.  Please see the exhibits for reconciliations of supplemental reporting measures and the supplemental information package for the quarter ended March 31, 2018, which is available on the company's website (www.welltower.com), for information and reconciliations of additional supplemental reporting measures.

About Welltower Welltower Inc. (NYSE: WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.  Welltower™, a real estate investment trust ("REIT"), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties. More information is available at www.welltower.com.  We routinely post important information on our website at www.welltower.com in the "Investors" section, including corporate and investor presentations and financial information.  We intend to use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Such disclosures will be included on our website under the heading "Investors".  Accordingly, investors should monitor such portion of the company's website in addition to following our press releases, public conference calls and filings with the Securities and Exchange Commission.  The information on our website is not incorporated by reference in this press release, and our web address is included as an inactive textual reference only.

Forward-Looking Statements and Risk Factors This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. When we use words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "pro forma," "estimate" or similar expressions that do not relate solely to historical matters, we are making forward-looking statements. In particular, these forward-looking statements include, but are not limited to, those relating to our opportunities to acquire, develop or sell properties; our ability to close anticipated acquisitions, investments or dispositions on currently anticipated terms, or within currently anticipated timeframes; the expected performance of our operators/tenants and properties; our expected occupancy rates; our ability to declare and to make distributions to shareholders; our investment and financing opportunities and plans; our continued qualification as a REIT; our ability to access capital markets or other sources of funds; and our ability to meet our earnings guidance. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause our actual results to differ materially from our expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators'/tenants' difficulty in cost-effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and seniors housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; our ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters and other acts of God affecting our properties; our ability to re-­lease space at similar rates as vacancies occur; our ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future investments or acquisitions; environmental laws affecting our properties; changes in rules or practices governing our financial reporting; the movement of U.S. and foreign currency exchange rates; our ability to maintain our qualification as a REIT; key management personnel recruitment and retention; and other risks described in our reports filed from time to time with the Securities and Exchange Commission. Finally, we undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, or to update the reasons why actual results could differ from those projected in any forward-looking statements.

For more information:
www.prnewswire.com/news-releases/welltower-reports-first-quarter-2018-results-300636948.html

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 26/04/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.